Abstract |
|
Authors | Sarah Frys, Zachary Simons, Qiang Hu, Matthew J Barth, Juan J Gu, Cory Mavis, Joseph Skitzki, Liu Song, Myron S Czuczman, Francisco J Hernandez-Ilizaliturri |
Journal | British journal of haematology
(Br J Haematol)
Vol. 169
Issue 4
Pg. 506-19
(May 2015)
ISSN: 1365-2141 [Electronic] England |
PMID | 25712263
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2015 John Wiley & Sons Ltd. |
Chemical References |
- Antibodies, Monoclonal, Murine-Derived
- BCL2L1 protein, human
- Benzamides
- Boronic Acids
- CDKN1A protein, human
- Cyclin-Dependent Kinase Inhibitor p21
- Histone Deacetylase Inhibitors
- Pyrazines
- Pyridines
- bcl-X Protein
- Cytarabine
- entinostat
- Rituximab
- Bortezomib
|
Topics |
- Animals
- Antibodies, Monoclonal, Murine-Derived
(pharmacology)
- Antineoplastic Combined Chemotherapy Protocols
(pharmacology)
- Apoptosis
(drug effects)
- Benzamides
(pharmacology)
- Boronic Acids
(pharmacology)
- Bortezomib
- Cell Line, Tumor
- Cyclin-Dependent Kinase Inhibitor p21
(metabolism)
- Cytarabine
(pharmacology)
- Drug Resistance, Neoplasm
(drug effects)
- Female
- G1 Phase Cell Cycle Checkpoints
(drug effects)
- Histone Deacetylase Inhibitors
(pharmacology)
- Humans
- Lymphoma, B-Cell
(drug therapy, metabolism, pathology)
- Male
- Mice
- Mice, SCID
- Pyrazines
(pharmacology)
- Pyridines
(pharmacology)
- Rituximab
- Xenograft Model Antitumor Assays
- bcl-X Protein
(metabolism)
|